Literature DB >> 20074982

Comparison between population average and experimentally measured arterial input function in predicting biopsy results in prostate cancer.

Ran Meng1, Silvia D Chang, Edward C Jones, S Larry Goldenberg, Piotr Kozlowski.   

Abstract

RATIONALE AND
OBJECTIVES: To test whether individually measured arterial input function (AIF) provides more accurate prostate cancer diagnosis then population average AIF when dynamic contrast-enhanced (DCE) magnetic resonance imaging (MRI) data are acquired with limited temporal resolution.
MATERIALS AND METHODS: Twenty-six patients with a high clinical suspicion for prostate cancer and no prior treatment underwent DCE MRI examination at 3.0 T before biopsy. DCE MRI data were fitted to a pharmacokinetic model using three forms of AIF: an individually measured, a local population average, and a literature double exponential population average. Receiver operating characteristic (ROC) analysis was used to correlate MRI with the biopsy results. Goodness of fit (chi(2)) for the three AIFs was compared using nonparametric Mann-Whitney test.
RESULTS: Average volume transfer constant (K(trans)) values were significantly higher in tumor than in normal peripheral zone for all three AIFs. The individually measured and the local population average AIFs had the highest sensitivity (76%), whereas the double exponential AIF had the highest specificity (82%). The areas under the ROC curves were not significantly different between any of the AIFs (0.81, 0.76, and 0.81 for the individually measured, local population average, and double exponential AIFs, respectively). chi(2) was not significantly different for the three AIFs; however, it was significantly higher in enhancing than in nonenhancing regions for all three AIFs.
CONCLUSIONS: These results suggest that, when DCE MRI data are acquired with limited temporal resolution, experimentally measured individual AIF is not significantly better than population average AIF in predicting the biopsy results in prostate cancer. Crown Copyright 2010. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20074982      PMCID: PMC2891013          DOI: 10.1016/j.acra.2009.11.006

Source DB:  PubMed          Journal:  Acad Radiol        ISSN: 1076-6332            Impact factor:   3.173


  28 in total

1.  Dynamic contrast enhanced MRI of prostate cancer: correlation with morphology and tumour stage, histological grade and PSA.

Authors:  A R Padhani; C J Gapinski; D A Macvicar; G J Parker; J Suckling; P B Revell; M O Leach; D P Dearnaley; J E Husband
Journal:  Clin Radiol       Date:  2000-02       Impact factor: 2.350

2.  Differentiation of prostate cancer from benign prostate hypertrophy using dual-echo dynamic contrast MR imaging.

Authors:  Satoshi Muramoto; Hidemasa Uematsu; Hirohiko Kimura; Yoshiyuki Ishimori; Norihiro Sadato; Nobuyuki Oyama; Tsuyoshi Matsuda; Yasutaka Kawamura; Yoshiharu Yonekura; Kenichiro Okada; Harumi Itoh
Journal:  Eur J Radiol       Date:  2002-10       Impact factor: 3.528

3.  Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach.

Authors:  E R DeLong; D M DeLong; D L Clarke-Pearson
Journal:  Biometrics       Date:  1988-09       Impact factor: 2.571

4.  Method for quantitative mapping of dynamic MRI contrast agent uptake in human tumors.

Authors:  M Rijpkema; J H Kaanders; F B Joosten; A J van der Kogel; A Heerschap
Journal:  J Magn Reson Imaging       Date:  2001-10       Impact factor: 4.813

5.  Prostatic carcinoma: staging by clinical assessment, CT, and MR imaging.

Authors:  H Hricak; G C Dooms; R B Jeffrey; A Avallone; D Jacobs; W K Benton; P Narayan; E A Tanagho
Journal:  Radiology       Date:  1987-02       Impact factor: 11.105

6.  Predictors of pathologic stage in prostatic carcinoma. The role of neovascularity.

Authors:  M K Brawer; R E Deering; M Brown; S D Preston; S A Bigler
Journal:  Cancer       Date:  1994-02-01       Impact factor: 6.860

7.  Prostate cancer detection with multi-parametric MRI: logistic regression analysis of quantitative T2, diffusion-weighted imaging, and dynamic contrast-enhanced MRI.

Authors:  Deanna L Langer; Theodorus H van der Kwast; Andrew J Evans; John Trachtenberg; Brian C Wilson; Masoom A Haider
Journal:  J Magn Reson Imaging       Date:  2009-08       Impact factor: 4.813

Review 8.  Functional tumor imaging with dynamic contrast-enhanced magnetic resonance imaging.

Authors:  Peter L Choyke; Andrew J Dwyer; Michael V Knopp
Journal:  J Magn Reson Imaging       Date:  2003-05       Impact factor: 4.813

9.  Discrimination of prostate cancer from normal peripheral zone and central gland tissue by using dynamic contrast-enhanced MR imaging.

Authors:  Marc R Engelbrecht; Henkjan J Huisman; Robert J F Laheij; Gerrit J Jager; Geert J L H van Leenders; Christina A Hulsbergen-Van De Kaa; Jean J M C H de la Rosette; Johan G Blickman; Jelle O Barentsz
Journal:  Radiology       Date:  2003-08-27       Impact factor: 11.105

10.  Quantitative measurements of prostatic blood flow and blood volume by positron emission tomography.

Authors:  T Inaba
Journal:  J Urol       Date:  1992-11       Impact factor: 7.450

View more
  17 in total

1.  A data-driven approach to prostate cancer detection from dynamic contrast enhanced MRI.

Authors:  Nandinee Fariah Haq; Piotr Kozlowski; Edward C Jones; Silvia D Chang; S Larry Goldenberg; Mehdi Moradi
Journal:  Comput Med Imaging Graph       Date:  2014-07-05       Impact factor: 4.790

2.  A comparison of two methods for estimating DCE-MRI parameters via individual and cohort based AIFs in prostate cancer: a step towards practical implementation.

Authors:  Andriy Fedorov; Jacob Fluckiger; Gregory D Ayers; Xia Li; Sandeep N Gupta; Clare Tempany; Robert Mulkern; Thomas E Yankeelov; Fiona M Fennessy
Journal:  Magn Reson Imaging       Date:  2014-01-21       Impact factor: 2.546

3.  Quantitative pharmacokinetic analysis of prostate cancer DCE-MRI at 3T: comparison of two arterial input functions on cancer detection with digitized whole mount histopathological validation.

Authors:  Fiona M Fennessy; Andriy Fedorov; Tobias Penzkofer; Kyung Won Kim; Michelle S Hirsch; Mark G Vangel; Paul Masry; Trevor A Flood; Ming-Ching Chang; Clare M Tempany; Robert V Mulkern; Sandeep N Gupta
Journal:  Magn Reson Imaging       Date:  2015-02-14       Impact factor: 2.546

4.  Correction of arterial input function in dynamic contrast-enhanced MRI of the liver.

Authors:  Hesheng Wang; Yue Cao
Journal:  J Magn Reson Imaging       Date:  2012-03-05       Impact factor: 4.813

5.  A comparison of individual and population-derived vascular input functions for quantitative DCE-MRI in rats.

Authors:  David A Hormuth; Jack T Skinner; Mark D Does; Thomas E Yankeelov
Journal:  Magn Reson Imaging       Date:  2014-01-07       Impact factor: 2.546

6.  Whole-lesion histogram and texture analyses of breast lesions on inline quantitative DCE mapping with CAIPIRINHA-Dixon-TWIST-VIBE.

Authors:  Kun Sun; Hong Zhu; Weimin Chai; Ying Zhan; Dominik Nickel; Robert Grimm; Caixia Fu; Fuhua Yan
Journal:  Eur Radiol       Date:  2019-08-01       Impact factor: 5.315

7.  Current and future trends in magnetic resonance imaging assessments of the response of breast tumors to neoadjuvant chemotherapy.

Authors:  Lori R Arlinghaus; Xia Li; Mia Levy; David Smith; E Brian Welch; John C Gore; Thomas E Yankeelov
Journal:  J Oncol       Date:  2010-09-29       Impact factor: 4.375

Review 8.  Multiparametric MRI of prostate cancer: an update on state-of-the-art techniques and their performance in detecting and localizing prostate cancer.

Authors:  John V Hegde; Robert V Mulkern; Lawrence P Panych; Fiona M Fennessy; Andriy Fedorov; Stephan E Maier; Clare M C Tempany
Journal:  J Magn Reson Imaging       Date:  2013-05       Impact factor: 4.813

9.  Parameterizing the Logistic Model of Tumor Growth by DW-MRI and DCE-MRI Data to Predict Treatment Response and Changes in Breast Cancer Cellularity during Neoadjuvant Chemotherapy.

Authors:  Nkiruka C Atuegwu; Lori R Arlinghaus; Xia Li; A Bapsi Chakravarthy; Vandana G Abramson; Melinda E Sanders; Thomas E Yankeelov
Journal:  Transl Oncol       Date:  2013-06-01       Impact factor: 4.243

10.  DCE-MRI analysis methods for predicting the response of breast cancer to neoadjuvant chemotherapy: pilot study findings.

Authors:  Xia Li; Lori R Arlinghaus; Gregory D Ayers; A Bapsi Chakravarthy; Richard G Abramson; Vandana G Abramson; Nkiruka Atuegwu; Jaime Farley; Ingrid A Mayer; Mark C Kelley; Ingrid M Meszoely; Julie Means-Powell; Ana M Grau; Melinda Sanders; Sandeep R Bhave; Thomas E Yankeelov
Journal:  Magn Reson Med       Date:  2013-05-09       Impact factor: 4.668

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.